Allison Humes Bartlett

Allison Humes Bartlett

Auto-generated profile, based on publicly available information

Allison Humes Bartlett

Department of Pediatrics, Section of Infectious Diseases, The University of Chicago Medicine, Chicago, Illinois

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2010 in The Anatomical Record
Verified
Journal Article
Open access
PDF file
KHKazutaka Hayashida
Kazutaka Hayashida
ABAllison H. Bartlett
Allison H. Bartlett
YCYe Chen
Ye Chen
PPPyong Woo Park
Pyong Woo Park
The extracellular domain of several membrane‐anchored proteins is released from the cell surface as soluble proteins through a regulated proteolytic mechanism called ectodomain shedding. Cells use ectodomain shedding to actively regulate the expression and function of surface molecules, and modulate a wide variety of cellular and physiological processes. Ectodomain shedding rapidly converts membrane‐associated proteins into soluble effectors and, at the same time, rapidly reduces the level of cell surface expression. For some proteins, ectodomain shedding is also a prerequisite for intramembrane proteolysis, which liberates the cytoplasmic domain of the affected molecule and associated signaling factors to regulate transcription. Ectodomain shedding is a process that is highly regulated by specific agonists, antagonists, and intracellular signaling pathways. Moreover, only about 2% of cell surface proteins are released from the surface by ectodomain shedding, indicating that cells selectively shed their protein ectodomains. This review will describe the molecular and cellular mechanisms of ectodomain shedding, and discuss its major functions in lung development and disease. Anat Rec, 293:925–937, 2010. © 2010 Wiley–Liss, Inc.

1 February 2010 in Expert Reviews in Molecular Medicine
Verified
Journal Article
Closed access
PDF file
ABAllison H. Bartlett
Allison H. Bartlett
PPPyong Woo Park
Pyong Woo Park
Many microbial pathogens subvert proteoglycans for their adhesion to host tissues, invasion of host cells, infection of neighbouring cells, dissemination into the systemic circulation, and evasion of host defence mechanisms. Where studied, specific virulence factors mediate these proteoglycan–pathogen interactions, which are thus thought to affect the onset, progression and outcome of infection. Proteoglycans are composites of glycosaminoglycan (GAG) chains attached covalently to specific core proteins. Proteoglycans are expressed ubiquitously on the cell surface, in intracellular compartments, and in the extracellular matrix. GAGs mediate the majority of ligand-binding activities of proteoglycans, and many microbial pathogens elaborate cell-surface and secreted factors that interact with GAGs. Some pathogens also modulate the expression and function of proteoglycans through known virulence factors. Several GAG-binding pathogens can no longer attach to and invade host cells whose GAG expression has been reduced by mutagenesis or enzymatic treatment. Furthermore, GAG antagonists have been shown to inhibit microbial attachment and host cell entry in vitro and reduce virulence in vivo. Together, these observations underscore the biological significance of proteoglycan–pathogen interactions in infectious diseases.

1 February 2009 in The American Journal of Pathology
Verified
Journal Article
Closed access
AHAtsuko Hayashida
Atsuko Hayashida
ABAllison H. Bartlett
Allison H. Bartlett
TFTimothy J. Foster
Timothy J. Foster
PPPyong Woo Park
Pyong Woo Park

1 April 2018 in Pediatrics
Verified
Journal Article
Open access
PDF file
JKJason Kane
Jason Kane
JCJeffrey D. Colvin
Jeffrey D. Colvin
ABAllison H. Bartlett
Allison H. Bartlett
MHMatt Hall
Matt Hall
BACKGROUND AND OBJECTIVES: There has been a rapid increase in the rate of pediatric opioid-related hospitalizations. It is unknown how this increase has impacted the use of pediatric critical care. Our objective in this study was to assess the trends in pediatric hospitalization for opioid ingestions in a cohort of US children’s hospitals and, specifically, to evaluate the impact on pediatric critical care resource use. METHODS: A retrospective cohort study of the Pediatric Health Information System was performed to identify hospitalizations for opioid ingestions from 2004 to 2015. Admission to the PICU and the use of naloxone, vasopressors, and ventilation were assessed by using billing data. The primary outcome measure was the trend in the rate of PICU admission for opioid-related ingestion over time, assessed by using Poisson regression. RESULTS: There were 3647 opioid-related hospitalizations in 31 hospitals; 42.9% required PICU care. The overall mortality was 1.6%, with annual deaths decreasing from 2.8% to 1.3% (P < .001). The number of opioid-related hospitalizations requiring PICU care doubled between 2004 and 2015. The rate of PICU admission for opioid-related hospitalization increased significantly, from 24.9 to 35.9 per 10 000 PICU admissions (P < .001). Among PICU admissions, 37.0% required mechanical ventilator support, and 20.3% required vasopressors. CONCLUSIONS: The US opioid crisis is negatively impacting children, and the rate of hospitalization and PICU admission for pediatric opioid ingestions is increasing. Current efforts to reduce adult opioid use have not curtailed the incidence of pediatric opioid ingestions, and additional efforts are needed to reduce preventable opioid exposure in children.

1 September 2010 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
ABAllison H. Bartlett
Allison H. Bartlett
KHKristina Hulten
Kristina Hulten

1 June 2017 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
DBDavid B. Banach
David B. Banach
BJB. Lynn Johnston
B. Lynn Johnston
DADuha Al-Zubeidi
Duha Al-Zubeidi
ABAllison H. Bartlett
Allison H. Bartlett
SBSusan Casey Bleasdale
Susan Casey Bleasdale
TPThe Outbreak Response Training Program (Ortp) Advisory Panel
The Outbreak Response Training Program (Ortp) Advisory Panel